术前Veterans Rand-12心理成分评分低于40分与初次全膝关节置换术后医疗资源利用增加及改善减弱相关
该回顾性研究纳入7,476例初次择期全膝关节置换术(TKA)患者,分析术前Veterans Rand-12心理成分评分(VR-12 MCS)与术后90天医疗资源利用及1年患者报告结局的关联。结果显示较低术前VR-12 MCS与延长住院、非家庭出院、1年KOOS疼痛临床获益及可接受症状状态(PASS)达标率降低相关;作者认为VR-12 MCS≤40可用于识别风险增高、指导术前讨论和潜在干预。
要点
- 术前VR-12 MCS 20-39分与延长住院(OR 1.46)及非家庭出院(OR 1.92)风险升高相关。
- 术前VR-12 MCS 20-39分患者1年PASS达标可能性较低(OR 0.74)。
- 术前VR-12 MCS>60分患者更可能家庭出院(OR 1.42)及1年KOOS-JR、疼痛临床获益和PASS达标。
核心结论
- 较低术前VR-12 MCS与TKA术后医疗资源利用增加及1年患者报告结局较差相关。
- 作者认为VR-12 MCS≤40可用于识别风险增高、指导术前讨论和潜在干预。
研究设计与样本
- 回顾性分析前瞻性收集的数据,纳入初次择期全膝关节置换术患者n=7,476例。
- 术前心理状态采用Veterans Rand-12心理成分评分(VR-12 MCS)评估。
- 采用多变量回归探究术前VR-12 MCS与结局指标的关联。
主要发现
- 共5,402例(72.3%)完成1年随访。
- 术前VR-12 MCS 20-39分与延长住院(>2天)风险升高相关(OR 1.46;P<.001)。
- 术前VR-12 MCS 20-39分与非家庭出院风险升高相关(OR 1.92;P<.001)。
- 术前VR-12 MCS 20-39分与90天再入院(P=.12)及再手术(P=.64)无显著关联。
- 术前VR-12 MCS 0-19分患者1年KOOS疼痛达到实质性临床获益的可能性较低(OR 0.25;P<.001)。
关键数值与推荐
- 术前VR-12 MCS 20-39分:延长住院OR 1.46(P<.001),非家庭出院OR 1.92(P<.001)。
- 术前VR-12 MCS 0-19分:1年KOOS疼痛实质性临床获益OR 0.25(P<.001)。
- 术前VR-12 MCS 20-39分:1年PASS达标OR 0.74(P=.002)。
- 术前VR-12 MCS>60分:家庭出院OR 1.42(P=.008),1年KOOS-JR实质性临床获益OR 1.16(P=.027)、KOOS疼痛实质性临床获益OR 1.220(P=.007)、PASS达标OR 1.28(P=.008)。
临床怎么用
- 作者认为VR-12 MCS≤40可用于识别风险增高的患者,并指导术前讨论和潜在干预。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adverse outcomes after total knee arthroplasty (TKA) have been associated with preoperative psychological disorders and poor mental health. We aimed to investigate and quantify the association between preoperative mental health and 1) postoperative 90-day health care utilization; and 2) 1-year patient-reported outcomes after primary TKA. METHODS: Retrospective review of prospectively collected data of patients who underwent primary elective TKA (n = 7,476) was performed. Preoperative mental health was evaluated using Veterans Rand-12 Mental Composite Scores (VR-12 MCS). Outcomes included prolonged length of stay (>2-days), nonhome discharge, 90-day readmissions, emergency department visits, and reoperation. Improvement in Knee Injury and Osteoarthritis Outcome Score (KOOS) and Patient Acceptable Symptom State (PASS) achievement were evaluated at 1-year. Multivariable regression was implemented to explore associations between preoperative VR-12 MCS and outcomes of interest. RESULTS: A total of 5,402 (72.3%) completed 1-year follow-up. Lower preoperative VR-12 MCS was associated with higher odds of prolonged length of stay (MCS 20-39: odds ratio (OR): 1.46;P < .001), and nonhome discharge disposition (MCS 20-39: OR: 1.92;P < .001), but not 90-day readmission or reoperation (MCS20-39; P = .12 and P = .64). At 1-year, patients with a lower MCS were less likely to attain a substantial clinical benefit in KOOS-pain (MCS 0-19; OR: 0.25; P < .001) and less likely to achieve PASS (MCS20-39; OR: 0.74; P = .002). Patients with an MCS >60 were more likely to be discharged home (OR: 1.42; P = .008), achieve substantial clinical benefit in their KOOS-JR (OR: 1.16; P = .027),-Pain (OR: 1.220; P = .007) and PASS at 1-year (OR: 1.28; P = .008). CONCLUSIONS: Lower VR-12 MCS is associated with increased postoperative health care utilization and worse patient-reported outcome measures at 1-year post-TKA. These findings suggest that a VR-12 MCS ≤40 could be used to designate increased risk, guide the preoperative discussion and potential interventions.
引用
- Rogers NB, Grits D, Emara AK, et al. Preoperative Veterans Rand-12 Mental Composite Score of < 40 Leads to Increased Healthcare Utilization and Diminished Improvement After Primary Knee Arthroplasty. J Arthroplasty. 2022. PMID: 35598758. doi:10.1016/j.arth.2022.05.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。